Kymera Therapeutics, Inc. (KYMR) Share-based Payment Arrangement, Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kymera Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Kymera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $12 M, a 27.5% increase year-over-year.
  • Kymera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $45.7 M, a 23.5% increase year-over-year.
  • Kymera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $43.1 M, a 21.5% increase from 2022.
  • Kymera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $35.5 M, a 42.1% increase from 2021.
  • Kymera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $25 M, a 381% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $45.7 M $12 M +$2.58 M +27.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $43.1 M $10.9 M +$1.99 M +22.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $41.1 M $11.7 M +$2.58 M +28.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $38.6 M $11.2 M +$1.56 M +16.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $37 M $9.39 M +$1.51 M +19.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $35.5 M $8.91 M +$231 K +2.66% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $35.2 M $9.08 M +$1.68 M +22.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $33.6 M $9.62 M +$3.9 M +68% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $29.7 M $7.87 M +$4.7 M +148% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $25 M $8.68 M +$6.85 M +375% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $18.1 M $7.4 M +$5.07 M +218% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $13.1 M $5.73 M +$5.06 M +762% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $7.99 M $3.17 M +$2.8 M +755% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $5.19 M $1.83 M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $2.33 M +$2.09 M +895% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $664 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $371 K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $234 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.